Recent research by the Alzheimer’s Association suggests that a person’s biological age, derived from a blood test, might indicate their risk of developing dementia.

Study Overview

Researchers in the United Kingdom analyzed data from the UK Biobank, which included over 223,000 participants. They focused on blood metabolites, which are small molecules associated with fat processing, inflammation, and energy usage. The study revealed that nearly 4,000 participants were diagnosed with dementia during the follow-up period.

Key Findings

The researchers developed a measure called the MileAge delta, which is the difference between a person’s metabolite-predicted age and their actual age. A higher MileAge delta suggests an older biological profile, while a lower one indicates a younger profile. Participants with a higher MileAge delta and genetic risk for dementia faced a 10 times greater risk for all-cause dementia.

The biological age marker, MileAge, was particularly predictive of vascular dementia, the second most common form of dementia.

Dr. Julian Mutz from King’s College London, a co-author of the study, highlighted the significant genetic risk associated with this metric. Higher MileAge delta and the presence of the APOE gene, which is linked to Alzheimer’s, increased the risk of all-cause dementia by tenfold. Vascular dementia had the strongest correlation.

Implications and Interventions

Mutz emphasized understanding risk factors beyond genetics. Biological aging, which can be measured through metabolites, can potentially be modified through lifestyle or medical interventions. Strategies include managing cardiovascular risk factors, staying physically active, and monitoring mental health. Modifying these risk elements can delay or even prevent dementia.

Expert Insights

Dr. Marc Siegel, a senior medical analyst, noted the study’s emphasis on the importance of ‘healthspan,’ especially in relation to the APOE gene which is known to provoke dementia. The combination of chronic illness and this gene increases the risk of vascular dementia by 60%. Risk factors like heart disease, high blood pressure, and obesity play significant roles.

Limitations of the Study

The study’s observational nature means it does not establish causation, only association, between older biological age and dementia risk. Additionally, the UK Biobank’s participants predominantly have healthier profiles and European ancestry, possibly skewing the results. The study utilized a single blood measurement, preventing tracking of biological aging changes over time. Researchers state that the MileAge marker needs more validation before clinical application.